Independence Bank of Kentucky’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
WA
AFG
GIC
IHL
EAM
AP
FMI
Independence Bank of Kentucky's IBB Position: Q2 2026 in Review
Independence Bank of Kentucky reduced its iShares Biotechnology ETF (IBB) stake by 47% in Q2 2026, selling an estimated $6.88K and leaving 45 shares worth $8.56K. The position accounts for ﹤0.01% of the portfolio, ranked #512.
Independence Bank of Kentucky first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. The position peaked at $32K in Q4 2022. 421 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Independence Bank of Kentucky held 45 shares of iShares Biotechnology ETF worth $8.56K as of Q2 2026.
- Independence Bank of Kentucky sold 40 iShares Biotechnology ETF shares in Q2 2026, an estimated $6.88K.
- iShares Biotechnology ETF made up ﹤0.01% of Independence Bank of Kentucky's portfolio in Q2 2026, its #512 holding.
- Independence Bank of Kentucky first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
- Independence Bank of Kentucky's iShares Biotechnology ETF position peaked at $32K in Q4 2022.
- 421 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.